Insider Shareholders with Direct Ownership of Athira Pharma, Inc. (ATHA)
This section provides a comprehensive overview of the insiders with direct ownership of Athira Pharma, Inc. (ATHA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Athira Pharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mark James Litton
President and CEO |
330,278 | 68,042 | 325,802 $123,804 | 15 |
Jul 01, 2025
Reduced 7.16%
|
|
Kevin Church
CHIEF SCIENTIFIC OFFICER |
152,322 | 24,587 | 168,901 $64,182 | 23 |
Jul 01, 2025
Reduced 4.81%
|
|
Glenna Mileson
Chief Financial Officer |
80,579 | 2,614 | 159,930 $60,773 | 10 |
Dec 28, 2022
Added 23.82%
|
| 30,003 | 0 | 144,884 $55,055 | 2 |
Jun 15, 2021
Added 0.69%
|
|
|
Mark Worthington
General Counsel and CCO |
128,147 | 24,587 | 111,875 $42,512 | 14 |
Jul 01, 2025
Reduced 7.08%
|
|
Robert Renninger
SVP, Finance and Accounting |
38,369 | 5,778 | 109,186 $41,490 | 6 |
Jul 01, 2025
Reduced 2.58%
|
|
Andrew Gengos
CFO and Chief Business Officer |
100,012 | 2,480 | 97,532 $37,062 | 8 |
Sep 05, 2024
Reduced 1.29%
|
|
Hans Moebius
Chief Medical Officer |
91,482 | 0 | 91,482 $34,763 | 11 |
Jan 04, 2024
Added 9.85%
|
| 80,400 | 0 | 80,715 $30,671 | 4 |
Jun 24, 2024
Added 25.34%
|
|
|
Martin Javier San
CHIEF MEDICAL OFFICER |
93,333 | 21,668 | 71,665 $27,232 | 4 |
Jul 01, 2025
Reduced 13.14%
|
| 25,000 | 0 | 25,783 $9,797 | 2 |
Mar 30, 2023
Added 36.78%
|
|
|
Rachel Lenington
COO and CDO |
30,000 | 9,130 | 20,870 $7,930 | 6 |
Sep 05, 2024
Reduced 10.79%
|
| 5,000 | 0 | 5,000 $1,900 | 1 |
Mar 29, 2023
Added 50.0%
|